TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 5 | 8 | -1 | 2 | 6 | -8 | 2 |
| P | %wins | 100 | 50 | 50 | 50 | 100 | 50 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/18/13 11:10 | 3/15/13 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Tulip Thomas H. | OH | O | EVP,Chie | P | 49 | 2.82 | 6 | 18 | 62 | 46 | D | -16 | -16 | 1 | -7 | -20 | -11 | -14 | -22 | 4 | -4 | 0 | -4 | 8 | -23 |
9/14/12 13:42 | 9/14/12 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Tulip Thomas H. | OH | H | EVP & Ch | P | 41 | 2.70 | 7 | 15 | 112 | 28 | D | 35 | -15 | -17 | -12 | -27 | -31 | -30 | -24 | 6 | 19 | -2 | 8 | 4 | 8 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |